CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 225

Industry reads hand-picked by our editors

Mar 21, 2019

Nature
Protein-slaying drugs could be the next blockbuster therapies
Regulatory Focus
OMB Reviews Proposal to Add Prices to Pharma TV Ads
Bloomberg
Cheaper Suboxone to be Sold By Indian Company Dr. Reddy’s

Mar 20, 2019

The Washington Post
God, country and chickenpox: How an outbreak entangled one school in a vaccine showdown
Reuters
Canada to create national drug agency to help cut cost of medicines
Xconomy
Flagship Reloads With $824M For Latest Growth Capital Fund

Mar 19, 2019

Kaiser Health News
Death By A Thousand Clicks: Where Electronic Health Records Went Wrong
The New York Times
Trump Plans to End the AIDS Epidemic. In Places Like Mississippi, Obstacles Are Everywhere.
STAT
The astounding 19-year journey to a sea change for heart patients

Mar 18, 2019

The Wall Street Journal
New Guidelines Advise Against Aspirin to Prevent Heart Disease
Financial Times
AstraZeneca places digital tech at core of blueprint for growth
Axios
Competition doesn't always drive down drug prices
The New York Times
Did Your Doctor Disappear Without a Word? A Noncompete Clause Could Be the Reason

Mar 15, 2019

CNN
OxyContin's maker is accused of fueling the opioid epidemic. Its new overdose antidote was just fast-tracked by the FDA
Financial Times
'Don’t think cash flow. Think profile. Think viral!'
Axios
Part of Trump's drug pricing plan is already happening
Pharmaphorum
Merck KGaA signs another AI deal

Mar 14, 2019

STAT
At a big cardiology meeting, glitzy tech will collide with sober science
NPR
Scientists Call For Global Moratorium On Creating Gene-Edited Babies
The Hill
Divisions emerge over House drug price bills

Mar 13, 2019

Bloomberg
Bristol-Myers CEO Says Celgene Purchase Not a 'Defensive' Move
The New York Times
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say
Reuters
BioNTech hires banks for IPO worth up to $800 million: sources
Vox
Abortions by mail: the FDA is going after online pill providers

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Understanding Publication Impact and Engagement with Data and AI-Driven Solutions Webinar - on demand • Provided by Altmetric
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.